IDXX NASDAQ
Credit Risk of going bust: lower than 88% of companies Debt: 2.4% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $1.50 (down 99.7%), IDEXX Laboratories, Inc. would be worth roughly what it owes.
Total debt $1.10B against a stock market value of $44.22B.
Distance to default 12.75 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $818.9M (short-term plus half of long-term), stock volatility 31.9%; Altman Z'' 10.84. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Westbrook, ME 04092
US
IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Kingsley Lawrence D | M-Exempt | 2,203 | $114.17 | 2026-09-04 |
| Kingsley Lawrence D | S-Sale | 2,203 | $532.08 | 2026-09-04 |
| Kingsley Lawrence D | M-Exempt | 2,203 | $114.17 | 2026-09-04 |
| Emerson Andrew | M-Exempt | 265 | $178.26 | 2026-08-20 |
| Emerson Andrew | F-InKind | 86 | — | 2026-08-20 |